Health Economics & Outcomes Research (HEOR)
and
Market Access
At Clinical Research Advancement, we understand that successful product adoption and reimbursement depend not only on clinical efficacy but also on demonstrating clear economic value and real-world outcomes.
Our HEOR and Market Access services bridge the gap between clinical data and healthcare decision-making to maximize market penetration and patient access worldwide.
Global Insights with a US Foundation
Rooted in deep expertise from the US healthcare landscape, we provide strategic insights that inform value demonstration across diverse healthcare systems. By leveraging US HEOR methodologies and payer engagement experience, we help clients shape compelling evidence, while adapting approaches to meet the unique needs of APAC, the Middle East, and African markets.
What We Offer:
- Health Economic Modeling & Budget Impact Analysis
Develop robust models that forecast product value and budget impact in target healthcare environments, enabling payers and providers to make informed decisions. - Real-World Evidence (RWE) Generation
Design and implement patient-centric, data-driven studies, including observational research and registry development, to demonstrate treatment effectiveness in routine clinical practice. - Value Proposition Development & Pricing Strategy
Craft tailored value frameworks aligned with regional payer expectations, optimizing pricing strategies to enhance access and reimbursement outcomes. - Market Access Strategy & Payer Engagement
Support early and ongoing dialogue with payers and health technology assessment (HTA) bodies worldwide, ensuring alignment between evidence generation and market needs. - Cross-Regional Adaptation & Comparative Effectiveness Research
Customize HEOR strategies to accommodate the economic, cultural, and regulatory landscapes of APAC, the Middle East, and Africa, underpinning evidence with relevant local data and comparisons.
Why Partner with Clinical Research Advancement?
Our global perspective, combined with specialized regional expertise, enables us to deliver HEOR and market access solutions that drive meaningful outcomes.
With Clinical Research Advancement, unlock the true value of your innovations—delivering evidence-based strategies that not only meet payer requirements but also improve patient access worldwide.
Success Stories
Accelerating Market Access for a Novel Oncology Therapy Across APAC and MEA
Challenge:
A global pharmaceutical company developing an innovative oncology therapy faced complex market access hurdles across diverse APAC, Middle Eastern and African markets, each with unique payer requirements and health economic landscapes.
Solution:
Clinical Research Advancement designed and executed a customized HEOR strategy grounded in US-based economic modeling but adapted for local contexts. We developed regional budget impact models, real-world evidence studies, and payer-targeted value dossiers.
Outcome:
Our strategic approach shortened payer review times by 30%, increased reimbursement approvals across five key markets, and facilitated early patient access programs that enhanced uptake. The client reported successful launches supported by strong value communication customized to each region.
Enhanced Value Demonstration for a Rare Disease Product in Emerging Markets
Challenge:
A biotech company needed to demonstrate clear economic and clinical value for a rare disease medication to secure reimbursement and broaden patient access in challenging emerging markets in Africa and the Middle East.
Solution:
Our team conducted comprehensive comparative effectiveness research alongside real-world evidence collection to provide compelling data on clinical benefits and healthcare resource utilization. We integrated local stakeholder insights to build culturally relevant value propositions and pricing strategies.
Outcome:
The client achieved a 40% increase in successful reimbursement negotiations within the first year, expanding market presence and significantly improving patient access in previously underserved countries.